By Holguin, Fernando; Folch, Erik; Redd, Stephen C; Mannino, David M
Study objectives: COPD is one of the leading causes of mortality and morbidity in the United States, yet little is known about the prevalence of comorbid conditions and mortality in hospitalized patients with COPD.
Design: From the National Hospital Discharge Survey, 1979 to 2001, we evaluated whether or not COPD in adults ≥ 25 years old is associated with increased prevalence and in-hospital mortality of several comorbidities.
Results: During 1979 to 2001, there were an estimated total of 47,404,700 hospital discharges (8.5% of all hospitalizations in adults > 25 years old) of patients with COPD; 37,540,374 discharges (79.2%) were made with COPD as a secondary diagnosis, and 9,864,278 discharges (20.8%) were made with COPD as the primary diagnosis. The prevalence and in-hospital mortality for pneumonia, congestive heart failure, ischemic heart disease, thoracic malignancies, and respiratory failure were larger in hospital discharges with any mention of COPD.
Conclusions: In a nationally representative sample of hospitalizations, any mention of COPD in the discharge diagnosis is associated with higher hospitalization prevalence and in-hospital mortality from other comorbidities. These results highlight the fact that the burden of disease associated with COPD is likely underestimated. (CHEST 2005; 128:2005-2011)
Key words: COPD; comorbidity; in-hospital mortality
Abbreviations: ICD-9 = International Classification of Diseases, Ninth Revision; NHDS = National Hospital Discharge Survey
COPD is the fourth-most-common cause of death in adults in the United States and is projected to be the third-most-common cause of death in both men and women by the year 2020.1 COPD is also a leading cause of hospitalisations in adults in the United States, particularly in older populations.2 Even though the prevalence of COPD has increased in the last 20 years,3 COPD is infrequently mentioned as a contributing or underlying cause of death even in patients with severe disease.4,5 Although this has been attributed to an underreporting bias, it is also possible that COPD increases the risk of dying from other comorbid conditions. Since nonrespiratory diseases account for > 50% of the underlying causes of death in COPD,5 it is likely that the impact of COPD as a health burden is substantially underestimated. We hypothesized that patients discharged from the hospital with a diagnosis of COPD have a higher prevalence and in-hospital mortality from comorbidities when compared to patients discharged without a diagnosis of COPD. To determine this, we analyzed the prevalence and mortality from selected comorbidities in patients with and without a diagnosis of COPD using the National Hospital Discharge Survey (NHDS) [1979 to 2001].
MATERIALS AND METHODS
The NHDS is a national survey that has heen conducted continuously since 1965, and it provides data on inpatient utilization of non-Federal, short-stay hospitals in the United States. NHDS data are collected from a sample of inpatient records acquired from a national prolmhility sample of hospitals. Because persons with multiple discharges during the year can be sampled more than once, the NHDS produces estimates for discharges, not persons. Only general hospitals, children’s general hospitals, or hospitals with an average length of stay
Analysis
We used ICD-9 codes 490-492 and 496 to define COPD. and included COPD as either primary (first diagnosis listing) or secondary discharge diagnosis (from the second to the seventh diagnosis listing). We evaluated whether having a primary or secondary diagnosis of COPD in adults ≥ 25 years old was associated with increased prevalence and mortality from the following selected comorbidibcs: pneumonia (ICD-9 480-487.8); hypertension (ICD-9 401- 406); diabetes (ICD-9 250); heart failure (ICD-9 428); ischemic heart disease (ICD-9 410-414); pulmonary vascular disease (ICD9 415- 417, which includes acute cor pulmonale, pulmonary embolism, primary and secondary pulmonary hypertension, and cor pulmonale not otherwise specified); thoracic malignancies (ICD-9 160-165); and ventilatory failure (defined as acute respiratory failure [ICD-9 518.81]; pulmonary insufficiency following trauma or surgery [ICD-9 518.5]; asphyxia and respiratory arrest [ICD-9 799], respiratory distress [ICD-9 786.09]); acute renal failure (ICD-9 584); chronic renal failure (ICD-9 585-586); HIV (ICD-9 042); cerebrovascular accident (ICD-9 430-438); and GI bleeding (ICD-9 578). To evaluate for any possible time-trend effects, we performed these analysis in five periods: 1979 to 1984, 1985 to 1988, 1989 to 1992, 1993 to 1996, and 1997 to 2001. Relative SEs were calculated using the weight for all-listed diagnosis provided in the 2000 NHDS data file documentation. We used the χ^sup 2^ test for differences between proportions and the Cochrane-Armitage test for trend using categorical data. For direct age adjustment using 2000 US population weights, a software program (PROC DESCRIPT in SUDAAN; Research Triangle Institute; Research Triangle Park, NC) was used. For analysis, we used statistical software (SAS version 8.0; SAS Institute; Cary, NC; and SUDAAN; Research Triangle Institute); p
RESULTS
During 1979 to 2001, there were an estimated total of 47,404,700 hospital discharges with a diagnosis of COPD its either the primary or secondary discharge diagnosis (8.5% of all hospitalisations in adults > 25 years old), of which 37,540,374 discharges (79.2%) were listed with COPD as a secondary diagnosis and 9,864,278 discharges (20.8%) were listed with COPD as the primary discharge diagnosis. From 1979 to 2001, the yearly prevalence of hospital discharges with a diagnosis of COPD increased significantly (p for trend
DISCUSSION
COPD is one of the leading causes for mortality and morbidity in the United States, yet little is known about the prevalence of comorbid conditions and specific causes of death in hospitalized patients with COPD.” In this analysis, hospital discharges with primary or secondary COPD were also more frequently diagnosed with other comorbid conditions, including cardiac and pulmonary vascular disease, pneumonia, and thoracic malignancies. Also, the in- hospital mortalityfrom congestive heart failure, hypertension, ischemic heart disease, and thoracic malignancies was higher among hospital discharges with any mention of COPD.
Progressive respiratory failure accounts for approximately one third of the COPD-related mortality; therefore, factors other than progression of lung disease must play a substantial role.9,10 For example, a long-standing history of tobacco abuse in COPD patients may increase the risk for comorbidities such as cardiovascular disease and cancer. Some of the most common comorbid conditions that have been described in association with COPD include hypertension, diabetes, coronary artery disease,10,11 heart failure,12 pulmonary infections, cancer, and pulmonary vascular disease.13 In a study14 of 312,664 decedents from England and Wales during 1993 to 1999, COPD was mentioned in 8.0% of all death certificates. In these death certificates, obstructive lung disease comprised 59.8% of the underlying cause of death. When obstructive lung disease was not the underlying cause of death, the most common causes of death were similar to those presented in our analysis (ischemic heart diseases, heart failure, malignant neoplasms of the lung, and bronchopneumonia).14
FIGURE 1. Percentage of hospital discharges with COPD as the underlying cause for hospitalization and for hospital discharges with COPD as secondary diagnosis, NHDS 1979 to 2001. Upper bar segment with white bars represent hospital discharges with COPD listed as a secondary hospital discharge diagnosis. Lower black segments represent hospital discharges with COPD listed as a primary hospital discharge diagnosis (p for trend
Table 1-Age Distribution of Hospital Discharges and In-hospital Mortality by a Primary or Secondary Discharge Diagnosis of COPD, NHDS 1979 to 2001
The number of preexisting comorbidities in patients with COPD has been associated with increased in-hospital mortality in a cross- sectional study15 of 71,130 patients admitted for COPD exacerbation. The in-hospital mortality from COPD exacerbations was 2.5%, which is considerably lower than the 5.9% in this study; this difference is probably explained by our broader inclusion of any mention of COPD in the discharge diagnoses. Comorbid conditions that have been associated with an increased mortality risk in COPD patients include chronic renal failure, cor pulmonale, and pulmonary vascular disease16; underlying heart diseases have not been consistently associated with a higher mortality risk.10 However, since COPD is frequently underreported, it is difficult to have an adequate estimate of how comorbid conditions influence COPD mortality or, inversely, how COPD affects the outcome of other diagnosis.4 For example, in a 22-year follow-up study of 5,542 adults in the first National Health and Nutrition Examination Survey, only 47.7% of patients with severe COPD at baseline had COPD listed in the death certificate, and only 23.1% had COPD listed as the underlying cause of death.”5
FIGURE 2. Estimated prevalence of hospital discharges with selected comorbidities in patients with and without COPD, NHDS 1979 to 2001. Bars represent the age-adjusted percentage with SE bars. Black burs show patients with COPD (either as primary or secondary discharge diagnosis). White bars show patients without any mention of a COPD discharge diagnosis. IHD = ischemic heart disease; CHF = congestive heart failure; RF = respiratory failure; PVD = pulmonary vascular disease; TM = thoracic malignancy. The prevalence of all listed comorbidities is different across COPD categories (p
The results from this study have several implications. First, this study shows that the burden of disease associated with COPD is largely underestimated, since having a diagnosis of COPD is associated with increase risk for hospitalisation and inhospital mortality from other common diagnoses. Second, the increase in the number of COPD-related hospital discharges since 1979 hits been largely due to COPD discharges listed as secondary diagnosis relative to COPD discharges listed as primary diagnosis. We believe that any combination of the following factors could account for this finding: (1) outpatient treatment may reduce the incidence of COPD exacerbations requiring hospitalization17 (which are also more likely to be labeled as a primary discharge diagnosis); however, outpatient treatment may not reduce the effect that COPD has on the risk of being hospitalized for other comorbid conditions; (2) only the most severe cases of COPD are recognized during hospitalization,18 thereby underestimating the number of hospital discharges where moderate or mild COPD could also be labeled as primary diagnosis; and (3) even in patients with severe COPD, a large proportion of patients are admitted to the hospital for other comorbidities,10 and therefore COPD is labeled as a secondary diagnosis.
Third, after adjusting for age, patients with COPD appear to have an increasing trend in the hospitalization and mortality prevalence for pneumonia, congestive heart failure, and ischemic heart disease when compared to patients without COPD (Fig 4). This finding might have important implications for developing prevention strategies such as influenza and pneumonia vaccination, and long-term oxygen treatment.
FIGURE 3. Estimated in-hospital mortality of hospital discharges associated with selected comorbidities in patients with and without COPD, NHDS 1979 to 2001. Bars represent the age-adjusted percentage with SE bars. Black bars show patients with COPD (either as primary or secondary discharge diagnosis). White bars show patients without any mention of a COPD discharge diagnosis. The in-hospital mortality for all listed comorbidities is dillerent across COPD categories (p
Several limitations must be considered when interpreting the results From this study. Our study has several potential sources for exposure misclassification: first, the use of ICD-9 codes and the ability of physicians to adequately diagnose COPD in hospitalized patients. Since ICD-9 coding for COPD has a low degree of sensitivity (29 to 53%)19 and physicians often fail to recognize mild-to-moderate cases of COPD in hospitalized patients,18 this would result in a selection bias that would underestimate the true prevalence of COPD-related hospital discharges; however, this bias would not affect the relationship between COPD and comorbid conditions observed in our analysis since this is nondifferential with regards to the presence of comorbidities. The association between COPD must be taken with caution due to residual confounding from a lack of adjustment for other covariates (gender, disease severity, medications used, and occupational exposure, among others). Further studies are needed to characterize the association of COPD and how it relates to the prevalence and in-hospital mortality from other comorbidities (ie, degree of airway obstruction, smoking history, functional status, and body mass index). Third, our study cannot address whether or not there is a causal association between a diagnosis of COPD and the selected comorbidities used in the analysis. Fourth, no stratified analyses were done to determine the effect of COPD according to race, type of hospital, and insurance; therefore, these results may not be applicable across all ethnic groups, which differ in health-care access and socioeconomic status. Fifth, the increasing trends in the hospitalisation prevalence and in-hospital mortality for ischemic heart disease, congestive heart failure, and pneumonia in patients with COPD should be taken with caution, since it is not possible to determine the extent to which other factors, such as changes in ICD coding patterns over time, could have affected these estimates.
FIGURE 4. Prevalence of hospitalization and in-hospital mortality for pneumonia, congestive heart failure, and ischemic heart disease in patients with and without COPD, NHDS 1971 to 2001. Prevalence and in-hospital mortality are age standardized to the 2000 US population. Relative SEs are
As shown in this study, a discharge diagnosis of COPD is associated with higher prevalence and inhospital mortality from selected comorbid conditions. Efforts toward earlier detection and treatment of COPD may result in decreasing the burden of disease.
* From the Division of Pulmonary, Allergy and Critical Care Medicine (Dr. Holguin) and Department of Medicine (Dr. Folch), Emory University School of Medicine; and Air Pollution and Respiratory Health Branch (Drs. Mannino and Redd), Division of Environmental Hazards and Health Effects, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA.
REFERENCES
1 Petty TL. Definition, epidemiology, course, and prognosis of COPD. Clin Cornerstone 2003; 5:1-10
2 Mannino DM. COPD; epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 2002; 121(suppl):121S- 126S
3 Mannino DM, Homa DM, Akimbami LJ, et al. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Morb Mortal Wkly Rep 2002; 51:1-16
4 Camilli AE, Rabbins DR, Lebowitz MD. Death certificate reporting of confirmed airways obstructive disease. Am J Epidemiol 1991; 133:795-800
5 Mannino DM, Brown C, Giovino GA. Obstructive lung disease in the United States from 1979 to 1993; an analysis using multiple- cause mortality data. Am J Respir Crit Care Med 1997; 156:814-818
6 Dennison CF, Pokras R. Design and operation of the National Hospital Discharge Survey: 1988 redesign. National Center for Health Statistics. Vital Health Stat 2000; 1:39
7 World Health Organization. International classification of dis\eases, ninth revision, clinical modification. (ICD-9-CM). Geneva, Switzerland: World Health Organization, 1978
8 Anto JM, Vermeire P, Vestbo J, et al. Epidemiology of chronic obstructive pulmonary disease. Eur Respir J 2001; 17:982-994
9 Vilkman S, Keistinen T, Tuuponen T, et al. Survival and cause of death among elderly chronic obstructive pulmonary disease patients after first admission to hospital. Respiration 1997; 64:281- 284
10 Zielinski J, MacNee W, Wedzicha J, et al. Causes of death in patients with COPD and chronic respiratory failure. Monaldi Arch Chest Dis 1997; 52:43-47
11 Behar S, Panosh A, Reicher-Reiss H, et al. Prevalence and prognosis of chronic obstructive pulmonary disease among 5,839 consecutive patients with acute myocardial infarction. SPRINT Study Group. Am J Med 1992; 93:637-641
12 Havranek EP, Masoudi FA, Westfall KA, et al. Spectrum of heart failure in older patients: results from the National Heart Failure project. Am Heart J 2002; 143:412-417
13 van Manen JG, Bindels FJ, Ijzennans CJ, et al. Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40. J Clin Epidemiol 2001; 54:287-293
14 Hansell AL, Walk JA, Soriano JB. What do chronic pulmonary disease patients die from? A multiple cause coding analysis. Eur Respir J 2003; 22:809-814
15 Paul SP, Krishnan AJ, Lechtzin N, et al. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med 2003; 163:1180-1186
16 Antonelli I, Fuso L, De Rosa M, et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997; 10:2794-2800
17 Cidulka RK, McFadden ER, Emerman CL, et al. Patterns of hospitalization in elderly patients with asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 156:1807-1812
18 Zaas D, Wise R, Wiener C. Airway obstruction is common but unsuspected in patients admitted to a general medicine service. Chest 2004; 125:106-111
19 Wilchesky M, Tamblyn RM, Huang A. Validation of diagnostic codes within medical service claims. J Clin Epidemiol 2004; 57:131- 141
Fernando Holguin, MD; Erik Folch, MD; Stephen C. Redd, MD; and David M. Mannino, MD, FCCP
This work was performed at the Centers for Disease Control and Prevention, Air Pollution and Respiratory Health Branch.
Manuscript received June 6, 2004; revision accepted March 23, 2005.
Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (www.chestjournal. org/misc/reprints.shtml).
Correspondence to: Fernando Holguin, MD, CDC/NCEH, 1600 Clifton Rd, NE MS E-17, Atlanta GA 30333; e-mail: [email protected]
Copyright American College of Chest Physicians Oct 2005
Comments